Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 4/20 | 1.00 |
| ▸ | LMNA | P02545 | 1/20 | 1.00 |
| ▸ | ACHE | P22303 | 1/20 | 0.51 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.49 |
| ▸ | PDE5A | O76074 | 1/20 | 0.48 |
| ▸ | PDE4A | P27815 | 1/20 | 0.48 |
| ▸ | PDE1A | P54750 | 1/20 | 0.48 |
| ▸ | PDE1B | Q01064 | 1/20 | 0.48 |
| ▸ | PDE4B | Q07343 | 1/20 | 0.48 |
| ▸ | PDE4C | Q08493 | 1/20 | 0.48 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.48 |
| ▸ | PDE3B | Q13370 | 1/20 | 0.48 |
| ▸ | PDE1C | Q14123 | 1/20 | 0.48 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.48 |
| ▸ | NPC1 | O15118 | 8/20 | 0.46 |
| ▸ | RAB9A | P51151 | 8/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 6/20 | 0.46 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.46 |
| ▸ | TP53 | P04637 | 3/20 | 0.45 |
| ▸ | MAPT | P10636 | 2/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30294185 | 1.00 | KDM4E (1.00) | KDM4ELMNAACHECYP3A4PDE5A | |
| SCHEMBL16870472 | 0.83 | KDM4E (0.71) | KDM4ELMNAACHECYP3A4PDE5A | |
| SCHEMBL29373878 | 0.83 | KDM4E (0.71) | KDM4ELMNACYP3A4PDE5APDE4A | |
| SCHEMBL31619335 | 0.81 | KDM4E (0.69) | KDM4ELMNACYP3A4PDE5APDE4A | |
| SCHEMBL10200281 | 0.81 | LMNA (0.69) | KDM4ELMNAACHECYP3A4PDE5A | |
| SCHEMBL15902735 | 0.81 | KDM4E (0.69) | KDM4ELMNACYP3A4PDE5APDE4A | |
| SCHEMBL1029836 | 0.80 | KDM4E (0.67) | KDM4ELMNACYP3A4PDE5APDE4A | |
| SCHEMBL2340155 | 0.77 | KDM4E (0.62) | KDM4ELMNAACHENPC1RAB9A | |
| SCHEMBL15680611 | 0.73 | KDM4E (0.57) | KDM4ELMNANPC1RAB9ASMN1; SMN2 | |
| SCHEMBL30017306 | 0.73 | PDE1A (0.74) | KDM4ELMNAACHECYP3A4PDE5A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 61 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4229639-A1 | METHOD AND SYSTEMS FOR PHYTOMEDICINE ANALYTICS FOR RESEARCH OPTIMIZATION AT SCALE | GBS Global Biopharma, Inc. (CA) | 2023-08-23 | — | — | EP | claimed |
| CN-115398011-A | Methods for predicting ixabepilone responsiveness in cancer patients | 亚拉勒提治疗欧洲私人有限公司 | 2022-11-25 | — | — | CN | claimed |
| WO-2022081889-A1 | METHOD AND SYSTEMS FOR PHYTOMEDICINE ANALYTICS FOR RESEARCH OPTIMIZATION AT SCALE | GBS GLOBAL BIOPHARMA, INC. (CA) | 2022-04-21 | — | — | WO | claimed |
| CN-112110932-A | Method for synthesizing phthalide tetrahydroisoquinoline compound by tandem cyclization strategy | 沈阳药科大学 | 2020-12-22 | — | — | CN | claimed |
| US-20260114475-A1 | ANIMAL FOOD COMPOSITIONS WITH IMPROVED PALATABILITY AND CUSTOMIZABILITY, AND METHODS FOR PREPARING THE SAME | MARS, INCORPORATED (US) | 2026-04-30 | — | — | US | disclosed |
| EP-4593631-A1 | ANIMAL FOOD COMPOSITIONS WITH IMPROVED PALATABILITY AND CUSTOMIZABILITY, AND METHODS FOR PREPARING THE SAME | Mars, Incorporated (US) | 2025-08-06 | — | — | EP | disclosed |
| WO-2024073025-A1 | ANIMAL FOOD COMPOSITIONS WITH IMPROVED PALATABILITY AND CUSTOMIZABILITY, AND METHODS FOR PREPARING THE SAME | MARS, INCORPORATED (US) | 2024-04-04 | — | — | WO | disclosed |
| EP-4344552-A1 | ANIMAL FOOD COMPOSITIONS WITH IMPROVED PALATABILITY, AND METHODS FOR PREPARING THE SAME | MARS, INCORPORATED (US) | 2024-04-03 | — | — | EP | disclosed |
| CN-117024423-A | Synthetic method of 3, 4-dihydro-isocoumarin-beta-carboline hybrid and analogue thereof | 伊犁师范大学 | 2023-11-10 | — | — | CN | disclosed |
| CN-110008578-B | Method, device and system for rapid detection of drugs and determination of drug absorption time | 山东国投鸿基检测技术股份有限公司 | 2023-03-28 | — | — | CN | disclosed |
| CN-113671078-B | Sepsis prognosis model establishing method based on metabonomics | 郑州大学第一附属医院 | 2023-03-03 | — | — | CN | disclosed |
| CN-115398011-A | Methods for predicting ixabepilone responsiveness in cancer patients | 亚拉勒提治疗欧洲私人有限公司 | 2022-11-25 | — | — | CN | disclosed |
| US-20120049055-A1 | DRUG DETECTION EQUIPMENT | HITACHI HIGH-TECH CORPORATION (JP) | 2012-03-01 | — | — | US | disclosed |
| EP-2423945-A2 | Drug detection equipment | Hitachi High-Technologies Corporation (JP) | 2012-02-29 | — | — | EP | disclosed |
| US-20100303935-A1 | Medicinal Composition | MCGINLEY PARTNERS, LLC (US) | 2010-12-02 | — | — | US | disclosed |
| US-20090263500-A1 | Composition and method for treating bedsores, cuts and burns | GORINSHTEYN BORIS | 2009-10-22 | — | — | US | disclosed |
| CN-1239547-A | pharmaceutical grade botanical drug | PHARMAPRINT INC (US) | 1999-12-22 | — | — | CN | disclosed |
| EP-0900375-A1 | PHARMACEUTICAL GRADE BOTANICAL DRUGS | Pharmaprint, Inc. (US) | 1999-03-10 | — | — | EP | disclosed |
| WO-1997039355-A1 | PHARMACEUTICAL GRADE BOTANICAL DRUGS | PHARMAPRINT, INC. (US) | 1997-10-23 | — | — | WO | disclosed |
| US-4122202-A | ANALGESIC, ANTIEDEMIC | SOCIETE CORTIAL (FR) | 1978-10-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100303935-A1 | Medicinal Composition | MUSK, TNNC1, ACHE | KDM4E 3689/4885LMNA 1925/4885ACHE 3/4885 |
| US-20260114475-A1 | ANIMAL FOOD COMPOSITIONS WITH IMPROVED PALATABILITY AND CUSTOMIZABILITY, AND METHODS FOR PREPARING THE SAME | PIGS, TAS2R13, CEL | KDM4E 984/4885LMNA 1459/4885ACHE 3373/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.